Two Sigma Advisers’s Cardiff Oncology CRDF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $648K | Buy |
205,600
+188,100
| +1,075% | +$593K | ﹤0.01% | 1631 |
|
|
2025
Q1 | $55K | Buy |
17,500
+2,700
| +18% | +$8.48K | ﹤0.01% | 2315 |
|
|
2024
Q4 | $64.2K | Sell |
14,800
-316,400
| -96% | -$1.37M | ﹤0.01% | 2266 |
|
|
2024
Q3 | $884K | Buy |
331,200
+124,200
| +60% | +$332K | ﹤0.01% | 1469 |
|
|
2024
Q2 | $460K | Buy |
207,000
+185,300
| +854% | +$411K | ﹤0.01% | 1915 |
|
|
2024
Q1 | $116K | Sell |
21,700
-17,500
| -45% | -$93.5K | ﹤0.01% | 2291 |
|
|
2023
Q4 | $58K | Sell |
39,200
-1,800
| -4% | -$2.66K | ﹤0.01% | 2389 |
|
|
2023
Q3 | $57K | Sell |
41,000
-131,800
| -76% | -$183K | ﹤0.01% | 2267 |
|
|
2023
Q2 | $254K | Buy |
172,800
+29,300
| +20% | +$43.1K | ﹤0.01% | 2033 |
|
|
2023
Q1 | $237K | Sell |
143,500
-43,400
| -23% | -$71.6K | ﹤0.01% | 2222 |
|
|
2022
Q4 | $262K | Sell |
186,900
-9,600
| -5% | -$13.4K | ﹤0.01% | 2111 |
|
|
2022
Q3 | $303K | Sell |
196,500
-138,300
| -41% | -$213K | ﹤0.01% | 2044 |
|
|
2022
Q2 | $737K | Sell |
334,800
-179,300
| -35% | -$395K | ﹤0.01% | 1744 |
|
|
2022
Q1 | $1.28M | Sell |
514,100
-150,900
| -23% | -$374K | ﹤0.01% | 1500 |
|
|
2021
Q4 | $4M | Sell |
665,000
-35,800
| -5% | -$215K | 0.01% | 867 |
|
|
2021
Q3 | $4.67M | Buy |
700,800
+35,600
| +5% | +$237K | 0.01% | 816 |
|
|
2021
Q2 | $4.42M | Buy |
665,200
+79,300
| +14% | +$527K | 0.01% | 920 |
|
|
2021
Q1 | $5.43M | Buy |
585,900
+467,600
| +395% | +$4.33M | 0.01% | 824 |
|
|
2020
Q4 | $2.13M | Buy |
+118,300
| New | +$2.13M | 0.01% | 1223 |
|